InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（1 笔）
内部人交易记录
其他已披露买入
2
已披露卖出
1
T+90 胜率
50%
T+90 平均收益
-0.6%
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the complete record of transactions filed by Morrison Briggs. Insider active across 4 companies, notably Syndax Pharmaceuticals Inc. Aggregated, 24 disclosures have been logged. Breakdown: 2 buys · 1 sell. Total volume traded: €518k. History available since 17 September 2021. The latest transaction was disclosed on 6 March 2026 (Acquisition). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Morrison Briggs
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报24 总计
15,527 股Common StockSEC:0001628280-26-045786:0
20,000 股@ US$13.403526.0% 占其流量Common StockSEC:0001628280-26-016003:0
标准退出：2026年6月4日 (T+90)
30,000 股@ US$7.56729.2% 占其流量Common StockSEC:0001628280-25-042536:0
标准退出：2025年12月21日 (T+90)
16,025 股0Common StockSEC:0001655759-25-000122:0
5,899 股0Common StockSEC:0001655759-24-000083:0
17,000 股0Common StockSEC:0001562180-24-001216:0
52,855 股@ US$8.779.3% 占其流量Common StockSEC:0001562180-23-006262:0
52,855 股@ US$8.779.3% 占其流量Common StockSEC:0001562180-23-005845:0
4,121 股0Common StockSEC:0001655759-23-000065:0
24,582 股@ US$6.383.2% 占其流量Common StockSEC:0001562180-23-005057:0
52,855 股@ US$6.386.8% 占其流量Common StockSEC:0001562180-23-004032:0
52,855 股@ US$6.386.8% 占其流量Common StockSEC:0001562180-23-003521:0
52,854 股@ US$6.387.0% 占其流量Common StockSEC:0001562180-23-002770:0
12,175 股Common StockSEC:0001104659-23-030746:0
52,854 股@ US$6.386.9% 占其流量Common StockSEC:0001562180-23-001117:0
114,339 股@ US$10.9027.4% 占其流量Common StockSEC:0001562180-22-006788:0
87,645 股@ US$7.2013.9% 占其流量Common StockSEC:0001562180-22-006706:0
62,292 股@ US$7.209.4% 占其流量Common StockSEC:0001562180-22-005475:0
16,188 股@ US$16.0026.9% 占其流量Common StockSEC:0001209191-22-024674:0
70,545 股@ US$7.2034.7% 占其流量Common StockSEC:0001562180-22-003383:0
6,000 股@ US$17.43897.2% 占其流量Common StockSEC:0001562180-22-003223:0
16,188 股@ US$16.0025.4% 占其流量Common StockSEC:0000899243-22-002557:0
35,156 股@ US$10.9025.6% 占其流量Common StockSEC:0001562180-21-007810:0
70,262 股@ US$7.2032.5% 占其流量Common StockSEC:0001562180-21-006038:0
24 条申报中的 24 条
About Morrison Briggs
Morrison Briggs is a declarant and a director of Syndax Pharmaceuticals Inc, Arvinas, INC. and Carisma Therapeutics Inc. He has 24 filings in total, and across the sampled recent filings from 2021-09-21 to 2026-06-26, the reported volumes are EUR 423298 in purchases and EUR 94500 in sales, with option exercise as the most frequent transaction type.
